analyst
TL
NASDAQ · TLX
Telix Pharmaceuticals Limited
Healthcare · Biotechnology
$12.51
Up+$0.68 (+5.71%)
Updated Sep 18, 2026, 12:46 PM
SID Score
6.2/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 3.18B
- P/E ratio
- 133.11
- Dividend yield
- 0.00%
- 52-week range
- $7.20 – $13.11
- Volume
- 412.91K
- Avg. volume
- 128.55K
Price performance
TLX price history
1M range · 20 trading sessions · Daily adjusted prices
TLX closed at $12.51 after 20 trading sessions, up 0.68% for the selected period.
- Last close
- $12.51
- Period change
- +0.68%
- Period low
- $10.85
- Period high
- $12.83
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 17, 2026 | $12.45 | $12.7196 | $12.375 | $12.505 | 412.91K |
| Sep 16, 2026 | $12.22 | $12.22 | $11.625 | $11.83 | 642.23K |
| Sep 15, 2026 | $12.62 | $13.1098 | $12.59 | $12.83 | 1.08M |
| Sep 14, 2026 | $12.20 | $12.23 | $11.67 | $11.78 | 630.49K |
| Sep 11, 2026 | $11.75 | $11.75 | $11.1962 | $11.29 | 415.34K |
| Sep 10, 2026 | $12.10 | $12.20 | $11.88 | $11.90 | 337.79K |
| Sep 9, 2026 | $12.085 | $12.48 | $11.965 | $12.34 | 548.31K |
| Sep 8, 2026 | $12.07 | $12.21 | $11.98 | $11.98 | 336.39K |
| Sep 4, 2026 | $11.84 | $11.95 | $11.84 | $11.94 | 142.01K |
| Sep 3, 2026 | $11.70 | $11.78 | $11.61 | $11.74 | 139.77K |
| Sep 2, 2026 | $11.40 | $11.79 | $11.3801 | $11.45 | 239.37K |
| Sep 1, 2026 | $10.94 | $10.96 | $10.80 | $10.85 | 186.29K |
| Aug 31, 2026 | $11.28 | $11.28 | $11.04 | $11.09 | 121.91K |
| Aug 28, 2026 | $11.47 | $11.47 | $11.2066 | $11.29 | 88.53K |
| Aug 27, 2026 | $11.32 | $11.38 | $11.27 | $11.375 | 73.8K |
| Aug 26, 2026 | $11.26 | $11.34 | $11.07 | $11.13 | 123.3K |
| Aug 25, 2026 | $11.75 | $11.77 | $11.62 | $11.69 | 95.85K |
| Aug 24, 2026 | $11.46 | $11.76 | $11.46 | $11.68 | 266.38K |
| Aug 21, 2026 | $11.34 | $11.39 | $11.19 | $11.33 | 299.63K |
| Aug 20, 2026 | $12.26 | $12.48 | $12.06 | $12.42 | 368.57K |
Latest TLX news
The latest Smart Investors Daily articles mentioning TLX.
Stock researchResearch & News · SEC Filings
Loading stock research…